XOMA Royalty Corp. (XOMA)

26.45 +0.91 (+3.56%) USD  |  NASDAQ  |  Mar 04, 16:00
26.48 +0.03 (+0.11%) Pre-Market: 20:00
More

XOMA Royalty Research and Development Expense (% of Annual Revenues)

Research and Development Expense (% of Annual Revenues) Chart

View Research and Development Expense (% of Annual Revenues) for XOMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (% of Annual Revenues) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (% of Annual Revenues) Range, Past 5 Years

View Research and Development Expense (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (% of Annual Revenues) Benchmarks

View Research and Development Expense (% of Annual Revenues) Benchmarks
Start Trial
Mirum Pharmaceuticals, Inc. Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
Rezolute, Inc. --
DiaMedica Therapeutics, Inc. --
Gossamer Bio, Inc. Upgrade